3,200
Participants
Start Date
November 30, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
January 31, 2028
HBsAg RDT Women
HBsAg will be screened using finger-stick capillary blood during the ANC visit, simultaneously with the HIV test
Treatment by TDF if HBcrAg RDT positive
300mg per day or 300 mg every 2 days (if créatinine clearance is 30-50ml/min)
Treatment by TDF
300mg per day or 300 mg every 2 days (if créatinine clearance is 30-50ml/min)
Social sciences component
"The social sciences component only in Cambodia and Ivory Coast. 3 key sub-studies: i) a socio-economic and behavioral study ii) a health economic evaluation study, and iii) a health policy study.~A mixed-methods approach will be used, including qualitative interviews and quantitative questionnaires among pregnant women and healthcare workers"
HBsAg RDT Infants
At 9 months, all infants will be tested for HBsAg; HBsAg-positive infants will undergo HBV DNA testing, and DBS will be collected for biobank storage.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
ANRS, Emerging Infectious Diseases
OTHER_GOV